Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 609Generated: October 26, 2026

3-Bromopyridine → Tert-butyl 4-(pyridin-3-YL)piperazine-1-carboxylate

https://huagongshe.com/reaction/609

Reaction equation

Participants

RoleNameHCIDCharge
Reactant3-BromopyridineHCID 12286—
Reactanttert-Butyl piperazine-1-carboxylateHCID 143452—
ReagentSodium t-butoxideHCID 23676156—
CatalystBinap, (A+-)-HCID 634876—
CatalystBis(dibenzylideneacetone)palladiumHCID 9811564—
SolventTolueneHCID 1140—
ProductTert-butyl 4-(pyridin-3-YL)piperazine-1-carboxylateHCID 1167337329.23%

Reaction Conditions

Temperature85 °C

Reaction Steps

TRIS(DIBENZYLIDENEACETONE)DIPALLADIUM(0) (0.059 g, 0.06 mmol) and rac-2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (0.080 g, 0.13 mmol) were mixed together and evacuated and purged with nitrogen 3 times. toluene (31.6 ml) was added and the resulting mixture heated to 90°C for 10 minutes then cooled to room temperature. sodium tert-butoxide (0.465 g, 4.84 mmol), 3-bromopyridine (0.310 ml, 3.22 mmol) and tert-butyl piperazine-1-carboxylate (0.6 g, 3.22 mmol) were added and the resulting mixture was heated at 85 °C for 64 hours. The reaction mixture was cooled to RT and filtered through celite and concentrated to give an orange solid. The crude product was purified by flash silica chromatography, elution gradient 30 to 50% EtOAc in heptane. Pure fractions were evaporated to dryness to afford tert-butyl 4-(pyridin-3-yl)piperazine-1-carboxylate (0.248 g, 29.2 %) as a yellow oil which crystallised on standing.

Provenance & Evidence

Source dataset750 AstraZeneca ELN dataset
ORD IDord-7977e1a392644e76ab21a7fab838843f
Source note750 AstraZeneca ELN dataset